COMPLEMENT C3

Approval Year

Substance Class	Protein Created by `admin` on `Tue Apr 01 20:33:49 GMT 2025` Edited by `admin` on `Tue Apr 01 20:33:49 GMT 2025`
Protein Type	COMPLEMENT FACTOR
Protein Sub Type
Sequence Origin	HUMAN
Sequence Type	COMPLETE
Record UNII	UM18T01RY8
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

COMPLEMENT C3

Common Name

English

C3

Preferred Name

English

HUMAN COMPLEMENT C3

Common Name

English

CPAMD1

Common Name

English

Code System Code Type Description

FDA UNII

UM18T01RY8

Created by admin on Tue Apr 01 20:33:49 GMT 2025 , Edited by admin on Tue Apr 01 20:33:49 GMT 2025

PRIMARY

UNIPROT

P01024

Created by admin on Tue Apr 01 20:33:49 GMT 2025 , Edited by admin on Tue Apr 01 20:33:49 GMT 2025

PRIMARY

Glycosylation Type

HUMAN

Glycosylation Link Type	Site
N	1_63
N	1_917
N	1_1595

Related Record Type Details


					T3B2AIZ4BF

AL-78898A

INHIBITOR -> TARGET

Amount:


					FR7T6AM49L

Ebribafusp Alfa

LIGAND->TARGET

Comments:

anti-(human complement C3d) fragment

Interaction Type:

PRECLINICAL

Amount:


					E295WV8BRV

NGM-621

INHIBITOR -> TARGET

Amount:


					G3PS38JMS8

Vensobafusp alfa

INHIBITOR -> TARGET

Amount:


					E295WV8BRV

NGM-621

INHIBITOR -> TARGET

Comments:

BLOCKS ENZYMATIC CLEAVAGE OF C3 BY C3 CONVERTASE

Amount:


					TO3JYR3BOU

PEGCETACOPLAN

INHIBITOR -> TARGET

Comments:

Inhibits C3 activation

Amount:


					4Z4DFR9BX7

AMY-101

INHIBITOR -> TARGET

Structural Modifications

Modification Type	Location Site	Location Type	Residue Modified	Extent	Fragment Name	Fragment Approval
AMINO ACID SUBSTITUTION	[1_38] [1_70] [1_297] [1_303] [1_672] [1_968] [1_1321] [1_1573]				DEXFOSFOSERINE	VI4F0K069V

Name	Property Type	Amount	Referenced Substance	Defining	Parameters	References
MOL_WEIGHT	CHEMICAL
Molecular Formula	CHEMICAL